Literature DB >> 22236141

Differential regulation of acid sphingomyelinase in macrophages stimulated with oxidized low-density lipoprotein (LDL) and oxidized LDL immune complexes: role in phagocytosis and cytokine release.

Jean-Philip Truman1, Mohammed M Al Gadban, Kent J Smith, Russell W Jenkins, Nalini Mayroo, Gabriel Virella, Maria F Lopes-Virella, Alicja Bielawska, Yusuf A Hannun, Samar M Hammad.   

Abstract

Oxidized low-density lipoprotein (oxLDL) and oxLDL-containing immune complexes (oxLDL-IC) contribute to the formation of lipid-laden macrophages (foam cells). Fcγ receptors mediate uptake of oxLDL-IC, whereas scavenger receptors internalize oxLDL. We have previously reported that oxLDL-IC, but not free oxLDL, activate macrophages and prolong their survival. Sphingomyelin is a major constituent of cell membranes and lipoprotein particles and acid sphingomyelinase (ASMase) hydrolyses sphingomyelin to generate the bioactive lipid ceramide. ASMase exists in two forms: lysosomal (L-ASMase) and secretory (S-ASMase). In this study we examined whether oxLDL and oxLDL-IC regulate ASMase differently, and whether ASMase mediates monocyte/macrophage activation and cytokine release. The oxLDL-IC, but not oxLDL, induced early and consistent release of catalytically active S-ASMase. The oxLDL-IC also consistently stimulated L-ASMase activity, whereas oxLDL induced a rapid transient increase in L-ASMase activity before it steadily declined below baseline. Prolonged exposure to oxLDL increased L-ASMase activity; however, activity remained significantly lower than that induced by oxLDL-IC. Further studies were aimed at defining the function of the activated ASMase. In response to oxLDL-IC, heat-shock protein 70B' (HSP70B') was up-regulated and localized with redistributed ASMase in the endosomal compartment outside the lysosome. Treatment with oxLDL-IC induced the formation and release of HSP70-containing and IL-1β-containing exosomes via an ASMase-dependent mechanism. Taken together, the results suggest that oxLDL and oxLDL-IC differentially regulate ASMase activity, and the pro-inflammatory responses to oxLDL-IC are mediated by prolonged activation of ASMase. These findings may contribute to increased understanding of mechanisms mediating macrophage involvement in atherosclerosis.
© 2012 The Authors. Immunology © 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22236141      PMCID: PMC3372755          DOI: 10.1111/j.1365-2567.2012.03552.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  67 in total

1.  Cell surface ceramide controls translocation of transferrin receptor to clathrin-coated pits.

Authors:  Abo Bakr Abdel Shakor; Mona Mohamed Atia; Katarzyna Kwiatkowska; Andrzej Sobota
Journal:  Cell Signal       Date:  2011-11-09       Impact factor: 4.315

2.  NPC2 facilitates bidirectional transfer of cholesterol between NPC1 and lipid bilayers, a step in cholesterol egress from lysosomes.

Authors:  Rodney E Infante; Michael L Wang; Arun Radhakrishnan; Hyock Joo Kwon; Michael S Brown; Joseph L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-04       Impact factor: 11.205

3.  Oxidized LDL immune complexes and oxidized LDL differentially affect the expression of genes involved with inflammation and survival in human U937 monocytic cells.

Authors:  Samar M Hammad; Waleed O Twal; Jeremy L Barth; Kent J Smith; Antonio F Saad; Gabriel Virella; W Scott Argraves; Maria F Lopes-Virella
Journal:  Atherosclerosis       Date:  2008-05-28       Impact factor: 5.162

4.  Immunochemical characterization of purified human oxidized low-density lipoprotein antibodies.

Authors:  G Virella; S Koskinen; G Krings; J M Onorato; S R Thorpe; M Lopes-Virella
Journal:  Clin Immunol       Date:  2000-05       Impact factor: 3.969

5.  Sphingomyelinase, an enzyme implicated in atherogenesis, is present in atherosclerotic lesions and binds to specific components of the subendothelial extracellular matrix.

Authors:  S Marathe; G Kuriakose; K J Williams; I Tabas
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-11       Impact factor: 8.311

Review 6.  Exosomes as intercellular signalosomes and pharmacological effectors.

Authors:  Michel Record; Caroline Subra; Sandrine Silvente-Poirot; Marc Poirot
Journal:  Biochem Pharmacol       Date:  2011-03-01       Impact factor: 5.858

7.  Regulated secretion of acid sphingomyelinase: implications for selectivity of ceramide formation.

Authors:  Russell W Jenkins; Daniel Canals; Jolanta Idkowiak-Baldys; Fabio Simbari; Patrick Roddy; David M Perry; Kazuyuki Kitatani; Chiara Luberto; Yusuf A Hannun
Journal:  J Biol Chem       Date:  2010-08-31       Impact factor: 5.157

8.  Exosomes packaging APOBEC3G confer human immunodeficiency virus resistance to recipient cells.

Authors:  Atanu K Khatua; Harry E Taylor; James E K Hildreth; Waldemar Popik
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

9.  Ceramide generated by sphingomyelin hydrolysis and the salvage pathway is involved in hypoxia/reoxygenation-induced Bax redistribution to mitochondria in NT-2 cells.

Authors:  Junfei Jin; Qi Hou; Thomas D Mullen; Youssef H Zeidan; Jacek Bielawski; Jacqueline M Kraveka; Alicja Bielawska; Lina M Obeid; Yusuf A Hannun; Yi-Te Hsu
Journal:  J Biol Chem       Date:  2008-08-01       Impact factor: 5.157

Review 10.  Roles and regulation of secretory and lysosomal acid sphingomyelinase.

Authors:  Russell W Jenkins; Daniel Canals; Yusuf A Hannun
Journal:  Cell Signal       Date:  2009-06       Impact factor: 4.315

View more
  24 in total

1.  Guggulsterone and bexarotene induce secretion of exosome-associated breast cancer resistance protein and reduce doxorubicin resistance in MDA-MB-231 cells.

Authors:  Ji Na Kong; Qian He; Guanghu Wang; Somsankar Dasgupta; Michael B Dinkins; Gu Zhu; Austin Kim; Stefka Spassieva; Erhard Bieberich
Journal:  Int J Cancer       Date:  2015-04-27       Impact factor: 7.396

Review 2.  Role of sphingolipids in the biogenesis and biological activity of extracellular vesicles.

Authors:  Claudia Verderio; Martina Gabrielli; Paola Giussani
Journal:  J Lipid Res       Date:  2018-05-31       Impact factor: 5.922

Review 3.  Exosomes and other extracellular vesicles in host-pathogen interactions.

Authors:  Jeffrey S Schorey; Yong Cheng; Prachi P Singh; Victoria L Smith
Journal:  EMBO Rep       Date:  2014-12-08       Impact factor: 8.807

Review 4.  Accelerated vascular disease in systemic lupus erythematosus: role of macrophage.

Authors:  Mohammed M Al Gadban; Mohamed M Alwan; Kent J Smith; Samar M Hammad
Journal:  Clin Immunol       Date:  2015-01-28       Impact factor: 3.969

5.  Immune complex formation in human diabetic retina enhances toxicity of oxidized LDL towards retinal capillary pericytes.

Authors:  Dongxu Fu; Jeremy Y Yu; Mingyuan Wu; Mei Du; Ying Chen; Souzan A Abdelsamie; Yanchun Li; Junping Chen; Michael E Boulton; Jian-Xing Ma; Maria F Lopes-Virella; Gabriel Virella; Timothy J Lyons
Journal:  J Lipid Res       Date:  2014-03-10       Impact factor: 5.922

Review 6.  Transfer of extracellular vesicles during immune cell-cell interactions.

Authors:  Cristina Gutiérrez-Vázquez; Carolina Villarroya-Beltri; María Mittelbrunn; Francisco Sánchez-Madrid
Journal:  Immunol Rev       Date:  2013-01       Impact factor: 12.988

Review 7.  Extracellular vesicles as emerging targets in cancer: Recent development from bench to bedside.

Authors:  Kerui Wu; Fei Xing; Shih-Ying Wu; Kounosuke Watabe
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-10-18       Impact factor: 10.680

Review 8.  The Messenger Apps of the cell: Extracellular Vesicles as Regulatory Messengers of Microglial Function in the CNS.

Authors:  Adeyemi A Olanrewaju; Ramin M Hakami
Journal:  J Neuroimmune Pharmacol       Date:  2020-04-27       Impact factor: 4.147

9.  Acid sphingomyelinase is activated in sickle cell erythrocytes and contributes to inflammatory microparticle generation in SCD.

Authors:  Anthony O Awojoodu; Philip M Keegan; Alicia R Lane; Yuying Zhang; Kevin R Lynch; Manu O Platt; Edward A Botchwey
Journal:  Blood       Date:  2014-07-29       Impact factor: 22.113

10.  Tesaglitazar ameliorates non-alcoholic fatty liver disease and atherosclerosis development in diabetic low-density lipoprotein receptor-deficient mice.

Authors:  Bu-Chun Zhang; Wei-Ming Li; Xian-Kai Li; Meng-Yun Zhu; Wen-Liang Che; Ya-Wei Xu
Journal:  Exp Ther Med       Date:  2012-09-17       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.